Drug Trial Radar · NCT06361485
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Last checked: Nov 20, 2026Latest source record: Apr 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 25, 2024
Primary completion
Mar 31, 2027
Study completion Apr 1, 2028
Sponsor
- Lead sponsor
- R3 Stem CellIndustry
- Sponsor type
- Industry
- Collaborators
- R3 Medical Research
- First posted
- Apr 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.
Conditions
- Low Back Pain
Interventions
Lumbar Injections with 10cc's of Wharton's Jelly AllograftBiological
Low Back Injections with Minimal Manipulation Umbilical Cord Tissue
Primary outcomes
What the sponsor says the trial is designed to measure.
- C-reactive proteinTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- Erythrocyte sedimentation rateTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- Alanine transaminase (ALT)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- Aspartate transaminase (AST)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- Alkaline phosphatase (ALP)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- AlbuminTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- CreatinineTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
- Blood Urea Nitrogen (BUN)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
R3 Anti Aging Scottsdale
Scottsdale, Arizona · Recruiting
R3 Anti Aging Beverly Hills
Beverly Hills, California · Recruiting
Scheer Medical Wellness
New York, New York · Recruiting
Dr. Duc (Steve) Le, MD
Cleveland, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.